Catalent Biologics’ drug product CDMO services leverage advanced technologies and proven expertise to supply better biologics, biosimilars, vaccines, sterile injectables, and diluents to your patients.
With over 30 years’ experience offering process development, formulation, and analytical support from pre-clinical through commercialization, our seasoned team of experts strengthened by our global network of purpose-built facilities enables us to accelerate the development of your product to clinic and market.
Whether your molecule is destined for vials (liquid or lyophilized), syringes or cartridges, our drug product manufacturing experts are equipped to tech transfer and scale your programs leveraging our global network’s robust aseptic processing capabilities combined with our integrated secondary packaging support. With the right scale, capacity, and integrated offerings to support your programs, partner with Catalent and secure your supply from Phase 1 through commercial with our drug product CDMO services.
DRUG PRODUCT CDMO SERVICES LOCATIONS
